In the last trading session, 54,755,028 shares of the Zomedica Corp.(NYSE:ZOM) were traded, and its beta was 0.92. Most recently the company’s share price was $2.1, and it changed around -$0.18 or -0.08% from the last close, which brings the market valuation of the company to $1.99 Billion. ZOM currently trades at a discount to its 52-week high of $2.91, offering almost -38.57% off that amount. The share price’s 52-week low was $0.063, which indicates that the current value has risen by an impressive 97% since then. We note from Zomedica Corp.’s average daily trading volume that its 10-day average is 83.3 Million shares, with the 3-month average coming to 177.45 Million.
Zomedica Corp. stock received a consensus recommendation rating of Buy, based on a mean score of 2. If we narrow it down even further, the data shows that none out of 1 analysts rate the stock as a Sell; another but none rate it as Overweight. Among the rest, no body recommended ZOM as a Hold, whereas 1 deemed it a Buy, and no one rated it as Underweight. Zomedica Corp. is expected to report earnings per share of $0 for the current quarter.
Zomedica Corp. (NYSE:ZOM): Trading Information
Although ZOM has showed a red trend with a performance of -7.89% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of $2.56- on Tuesday, Feb 16 increased the stock’s daily price by 17.97%. The company’s shares are currently up 8.11% year-to-date, but still down -0.1829 over the last five days. On the other hand, Zomedica Corp. (NYSE:ZOM) is 1.2% up in the 30-day period. We can see from the shorts that 63.22 Million shares have been sold at a short interest cover period of 0.36 day(s).
The consensus price target as assigned by Wall Street analysts is $1.2, which translates to bears needing to reduce their stock price by -42.86% from its current value. Analyst projections state that ZOM is forecast to be at a low of $1.2 and a high of $1.2. In order for the stock price to hit the forecast high, the stock would need to surge -42.86% from its current level, while the stock would need to crash -42.86% from its current level to reach the projected low.
Zomedica Corp. (ZOM) projections and forecasts
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -28.5%. Zomedica Corp. earnings are expected to decrease by -4.5% in 2021, but the outlook is negative 0% per year for the next five years.
Zomedica Corp. (NYSE:ZOM)’s Biggest Investors
Upon looking at major shareholders, it appears that insiders hold 4.42% of Zomedica Corp. shares, and 6.33% of them are in the hands of institutional investors. The stock currently has a share float of 6.62%. Zomedica Corp. stock is held by 31 institutions, with Vanguard Group, Inc. (The) being the largest institutional investor. By Dec 30, 2020, it held 17.9% of the shares, which is about 19.34 Million shares worth $4.46 Million.
Cambridge Investment Research Advisors Inc., with 11.34% or 12.25 Million shares worth $2.83 Million as of Dec 30, 2020, holds the second largest percentage of outstanding shares.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Vanguard Total Stock Market Index Fund and Fidelity Extended Market Index Fund were the top two Mutual Funds as of Sep 29, 2020. The former held 10359255 shares worth $1.14 Million, making up 9.59% of all outstanding shares. On the other hand, Fidelity Extended Market Index Fund held roughly 2.3 Million shares worth around $529.76 Thousand, which represents about 2.13% of the total shares outstanding.